ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,094Medicare Part D Prescriptions Filled, Including Refills

Rank: 164 out of 780

$1.29M Total Retail Price of All Prescriptions

Rank: 24 out of 780

812 Patients Receiving at Least One Drug in Part D
32%Patients 65 Years and Older
93% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

8% of this provider’s 812 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

2% of this provider’s 5,047 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$92 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
AMLODIPINE BESYLATE 1,012 438 1 4
METFORMIN HCL 451 139 2 8
SIMVASTATIN 448 202 3 2
OMEPRAZOLE 429 135 4 3
TRAMADOL HCL 347 126 5 15
FUROSEMIDE 291 144 6 7
LISINOPRIL-HYDROCHLOROTHIAZIDE 271 80 7 26
PRAVASTATIN SODIUM 261 96 8 9
QUINAPRIL HCL 254 121 9 113
LISINOPRIL 250 78 10 6
HYDROCHLOROTHIAZIDE 248 97 11 10
TRIAMTERENE-HCTZ 247 96 12 37
POTASSIUM CHLORIDE 236 109 13 11
CARVEDILOL 223 126 14 14
MELOXICAM 200 69 15 16
ATORVASTATIN CALCIUM 177 80 16 12
CLONIDINE HCL 169 72 17 28
LEVOTHYROXINE SODIUM 161 60 18 5
HYDROCODONE-ACETAMINOPHEN 157 31 S3 19 1
LOSARTAN-HYDROCHLOROTHIAZIDE 154 53 20 33
DOXAZOSIN MESYLATE 143 87 21 97
RANITIDINE HCL 141 34 22 39
KLOR-CON M20 141 75 22 57
METOPROLOL TARTRATE 140 66 24 19
WARFARIN SODIUM 133 42 25 24
SUSTIVA 131 19 26 286
INSULIN SYRINGE 129 76 27 80
ALLOPURINOL 126 39 28 29
AMITRIPTYLINE HCL 124 22 R 29 48
GLIPIZIDE XL 123 50 30 176
GLIPIZIDE 121 52 31 74
METOPROLOL SUCCINATE 121 65 31 20
LAMIVUDINE-ZIDOVUDINE 120 18 33 288
CRESTOR 116 44 34 32
GABAPENTIN 116 33 34 13
ATENOLOL 113 22 36 21
LOSARTAN POTASSIUM 112 83 37 18
SINGULAIR 105 31 38 73
IBUPROFEN 104 16 39 93
TRUVADA 102 0 40 217
SERTRALINE HCL 102 16 40 27
CYCLOBENZAPRINE HCL 97 20 R 42 42
GLIPIZIDE ER 92 47 43 109
ATRIPLA 92 0 43 231
FLUTICASONE PROPIONATE 88 29 45 41
ENALAPRIL MALEATE 88 26 45 64
NORVIR 85 0 47 202
PROAIR HFA 83 0 48 62
LOVASTATIN 79 35 49 47
HUMULIN 70-30 76 49 50 106
KLOR-CON 10 76 30 50 90
VENTOLIN HFA 75 19 52 91
ISENTRESS 72 0 53 245
NEXIUM 71 24 54 22
AMLODIPINE BESYLATE-BENAZEPRIL 69 32 55 50
LANTUS 68 24 56 71
GLIMEPIRIDE 65 17 57 30
NAPROXEN 64 28 58 100
DIOVAN HCT 63 0 59 75
TRAZODONE HCL 58 34 60 35
PROMETHAZINE HCL 57 0 R 61 66
LANSOPRAZOLE 57 27 61 184
POLYETHYLENE GLYCOL 3350 56 24 63 79
PANTOPRAZOLE SODIUM 53 16 64 25
FAMOTIDINE 53 18 64 86
DIGOXIN 52 42 66 56
KLOR-CON M10 50 19 67 168
PHENYTOIN SODIUM EXTENDED 50 0 67 128
BYSTOLIC 50 24 67 118
ATENOLOL-CHLORTHALIDONE 50 31 67 182
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 20, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.